Normative data for multiple breath washout outcomes in school-aged Caucasian children
- PMID: 31862765
- DOI: 10.1183/13993003.01302-2019
Normative data for multiple breath washout outcomes in school-aged Caucasian children
Erratum in
-
"Normative data for multiple breath washout outcomes in school-aged Caucasian children." Pinelopi Anagnostopoulou, Philipp Latzin, Renee Jensen, et al. Eur Respir J 2020; 55: 1901302.Eur Respir J. 2022 Aug 18;60(2):1951302. doi: 10.1183/13993003.51302-2019. Print 2022 Aug. Eur Respir J. 2022. PMID: 35981729 No abstract available.
Abstract
Background: The multiple breath nitrogen washout (N2MBW) technique is increasingly used to assess the degree of ventilation inhomogeneity in school-aged children with lung disease. However, reference values for healthy children are currently not available. The aim of this study was to generate reference values for N2MBW outcomes in a cohort of healthy Caucasian school-aged children.
Methods: N2MBW data from healthy Caucasian school-age children between 6 and 18 years old were collected from four experienced centres. Measurements were performed using an ultrasonic flowmeter (Exhalyzer D, Eco Medics AG, Duernten, Switzerland) and were analysed with commercial software (Spiroware version 3.2.1, Eco Medics AG). Normative values and upper limits of normal (ULN) were generated for lung clearance index (LCI) at 2.5% (LCI2.5%) and at 5% (LCI5%) of the initial nitrogen concentration and for moment ratios (M1/M0 and M2/M0). A prediction equation was generated for functional residual capacity (FRC).
Results: Analysis used 485 trials from 180 healthy Caucasian children aged from 6 to 18 years old. While LCI increased with age, this increase was negligible (0.04 units·year-1 for LCI2.5%) and therefore fixed ULN were defined for this age group. These limits were 7.91 for LCI2.5%, 5.73 for LCI5%, 1.75 for M1/M0 and 6.15 for M2/M0, respectively. Height and weight were found to be independent predictors of FRC.
Conclusion: We report reference values for N2MBW outcomes measured on a commercially available ultrasonic flowmeter device (Exhalyzer D, Eco Medics AG) in healthy school-aged children to allow accurate interpretation of ventilation distribution outcomes and FRC in children with lung disease.
Copyright ©ERS 2020.
Conflict of interest statement
Conflict of interest: P. Anagnostopoulou has nothing to disclose. Conflict of interest: P. Latzin reports personal fees from Gilead, Novartis, Polyphor, Santhera, Schwabe, Vertex, Vifor and Zambon, as well as grants from Vertex, outside the submitted work. Conflict of interest: R. Jensen has nothing to disclose. Conflict of interest: M. Stahl reports personal fees from Vertex Pharmaceuticals, outside the submitted work. Conflict of interest: A. Harper has nothing to disclose. Conflict of interest: S. Yammine has nothing to disclose. Conflict of interest: J. Usemann has nothing to disclose. Conflict of interest: R.E. Foong has nothing to disclose. Conflict of interest: B. Spycher has nothing to disclose. Conflict of interest: G.L. Hall reports grants from the NHMRC and the Australia and USA CF Foundation, and non-financial support (loan of equipment) from ndd, during the conduct of the study. Conflict of interest: F. Singer reports personal fees from Vertex and Novartis, outside the submitted work. Conflict of interest: S. Stanojevic has nothing to disclose. Conflict of interest: M.A. Mall reports grants from the German Federal Ministry of Education and Research (82DZL004A1) and the Einstein Foundation Berlin (EP-2017-393), during the conduct of the study, and personal fees advisory board work, consultancy and lectures from Boehringer Ingelheim and Vertex Pharmaceuticals, outside the submitted work. Conflict of interest: F. Ratjen reports grants and personal fees for consultancy from Vertex, plus personal fees for consultancy from Novartis, Bayer, Roche and Genetech, outside the submitted work. Conflict of interest: K.A. Ramsey has nothing to disclose.
Comment in
-
A new breeze from an inspiring past: normality with multiple breath washout in school-aged children.Eur Respir J. 2020 Apr 3;55(4):2000485. doi: 10.1183/13993003.00485-2020. Print 2020 Apr. Eur Respir J. 2020. PMID: 32245778 No abstract available.
Similar articles
-
Improved agreement between N2 and SF6 multiple-breath washout in healthy infants and toddlers with improved EXHALYZER D sensor performance.J Appl Physiol (1985). 2021 Jul 1;131(1):107-118. doi: 10.1152/japplphysiol.00129.2021. Epub 2021 May 27. J Appl Physiol (1985). 2021. PMID: 34043468
-
Correction of sensor crosstalk error in Exhalyzer D multiple-breath washout device significantly impacts outcomes in children with cystic fibrosis.J Appl Physiol (1985). 2021 Sep 1;131(3):1148-1156. doi: 10.1152/japplphysiol.00338.2021. Epub 2021 Aug 5. J Appl Physiol (1985). 2021. PMID: 34351818
-
The utility of moment ratios and abbreviated endpoints of the multiple breath washout test in preschool children with cystic fibrosis.Pediatr Pulmonol. 2020 Mar;55(3):649-653. doi: 10.1002/ppul.24618. Epub 2020 Jan 3. Pediatr Pulmonol. 2020. PMID: 31899855
-
Inert gas washout in preschool children.Paediatr Respir Rev. 2005 Dec;6(4):239-45. doi: 10.1016/j.prrv.2005.09.009. Epub 2005 Nov 9. Paediatr Respir Rev. 2005. PMID: 16298306 Review.
-
Multiple-breath washout in preschool children--FRC and ventilation inhomogeneity.Paediatr Respir Rev. 2006;7 Suppl 1:S14-6. doi: 10.1016/j.prrv.2006.04.019. Epub 2006 Jun 5. Paediatr Respir Rev. 2006. PMID: 16798542 Review.
Cited by
-
Diagnostic accuracy of peripheral lung function measurements in paediatric asthma control assessment: a pilot study.Postepy Dermatol Alergol. 2023 Dec;40(6):772-778. doi: 10.5114/ada.2023.133831. Epub 2024 Jan 8. Postepy Dermatol Alergol. 2023. PMID: 38282871 Free PMC article.
-
Lung clearance index short-term variability in cystic fibrosis: a pre-post pulmonary exacerbation study.Ital J Pediatr. 2024 Jan 17;50(1):6. doi: 10.1186/s13052-023-01574-w. Ital J Pediatr. 2024. PMID: 38233941 Free PMC article.
-
Risk of CFTR-related disorders and cystic fibrosis in an Italian cohort of CRMS/CFSPID subjects in preschool and school age.Eur J Pediatr. 2024 Feb;183(2):929-938. doi: 10.1007/s00431-023-05359-5. Epub 2023 Dec 6. Eur J Pediatr. 2024. PMID: 38054992
-
Pulmonary Evaluation in Children with Post-COVID-19 Condition Respiratory Symptoms: A Prospective Cohort Study.J Clin Med. 2023 Nov 1;12(21):6891. doi: 10.3390/jcm12216891. J Clin Med. 2023. PMID: 37959356 Free PMC article.
-
Automatic analysis of bronchus-artery dimensions to diagnose and monitor airways disease in cystic fibrosis.Thorax. 2023 Dec 15;79(1):13-22. doi: 10.1136/thorax-2023-220021. Thorax. 2023. PMID: 37734952 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources